Frühe Marktzutritte im Arzneimittelsektor : Anreize, Ausgestaltung und kartellrechtliche Bewertung

»Early Entry Agreements in the Pharmaceutical Industry«According to the European Commission's report on the Pharmaceutical Sector Inquiry practically all originator companies have developed a tool-box of instruments for how to prepare for and react to generic entry. The inquiry, inter alia, dealt with so-called authorised generics resulting from early-entry agreements between originator and generic companies. This study analyses the practise of authorised generics under German and European Competition Law, also considering the legal situation in the U.S.